Optas »

Vertex Pharmaceuticals Incorporated shares owned by Optas

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Optas from 13F filings

Historical chart of Optas investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Optas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Optas

Quarter filed Position value Share count Share price at filing
2024-03-31 $315k 754 418.00
2023-12-31 $303k 745 406.89
2023-09-30 $256k 735 347.73
2023-06-30 $252k 716 351.91
2023-03-31 $223k 707 315.07
2020-09-30 $368k 1.4k 272.57
2020-06-30 $256k 882 290.27
2020-03-31 $241k 1.0k 236.97
2019-12-31 $220k 1.0k 218.25

More positions owned by Optas

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Alphabet Cap Stk Cl C (GOOG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)

View all positions for Optas

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated